The Traderszone Network

Published in TZ Latest News 20 August, 2015 by The TZ Newswire Staff

New Skin Cancer Drugs Delayed (but Investors and Patients Needn’t Worry)

FDA decisions for Bristol-Myers Sqibb’s Opdivo and Merck’s Keytruda get pushed back.